Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details
Viemed Healthcare (NASDAQ:VMD) will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025 at 11:00 a.m. ET. Participants can join by phone at (877) 407-6176 (US toll-free) or +1 (201) 689-8451 (international), or via live audio webcast at https://event.choruscall.com/mediaframe/webcast.html?webcastid=asCOlSnC. A replay will be available in the Investor Relations section of Viemed's website at https://www.viemed.com. The call covers Viemed's Q3 2025 results and related commentary for investors and analysts.
Viemed Healthcare (NASDAQ:VMD) terrà la Conference Call sui Risultati del Terzo Trimestre 2025 il giovedì 6 novembre 2025 alle 11:00 ET. I partecipanti possono collegarsi telefonicamente al numero (877) 407-6176 (US toll-free) oppure +1 (201) 689-8451 (internazionale), oppure tramite webcast audio in diretta all'indirizzo https://event.choruscall.com/mediaframe/webcast.html?webcastid=asCOlSnC. Una riproduzione sarà disponibile nella sezione Relazioni con gli Investitori del sito di Viemed all'indirizzo https://www.viemed.com. La conferenza riguarda i risultati del Q3 2025 di Viemed e i relativi commenti per investitori e analisti.
Viemed Healthcare (NASDAQ:VMD) celebrará su Conferencia de Resultados del Tercer Trimestre 2025 el jueves 6 de noviembre de 2025 a las 11:00 a.m. hora del Este. Los participantes pueden unirse por teléfono al (877) 407-6176 (gratuito en EE. UU.) o al +1 (201) 689-8451 (internacional), o a través del webcast de audio en vivo en https://event.choruscall.com/mediaframe/webcast.html?webcastid=asCOlSnC. Una repetición estará disponible en la sección de Relaciones con Inversores del sitio web de Viemed en https://www.viemed.com. La llamada cubre los resultados del Q3 2025 de Viemed y comentarios relacionados para inversionistas y analistas.
Viemed Healthcare (NASDAQ:VMD)는 2025년 3분기 실적 컨퍼런스 콜을 2025년 11월 6일 목요일 동부 표준시 11:00 a.m.에 개최합니다. 참가자는 전화로 (877) 407-6176 (미국 무료) 또는 +1 (201) 689-8451 (국제)로 연결하거나, 라이브 오디오 webcast https://event.choruscall.com/mediaframe/webcast.html?webcastid=asCOlSnC를 통해 참여할 수 있습니다. 재생은 Viemed 웹사이트의 투자자 관계 섹션 https://www.viemed.com에서 이용 가능합니다. 이 콜은 Viemed의 2025년 3분기 실적 및 투자자와 애널리스트를 위한 관련 논평을 다룹니다.
Viemed Healthcare (NASDAQ:VMD) organisera son Appel de résultats du troisième trimestre 2025 le jeudi 6 novembre 2025 à 11h00, heure de l’Est. Les participants peuvent joindre par téléphone au (877) 407-6176 (gratuit aux États-Unis) ou au +1 (201) 689-8451 (international), ou via le webcast audio en direct à https://event.choruscall.com/mediaframe/webcast.html?webcastid=asCOlSnC. Une rediffusion sera disponible dans la section Investisseurs du site Viemed à https://www.viemed.com. L’appel couvre les résultats du T3 2025 de Viemed et les commentaires associés pour les investisseurs et les analystes.
Viemed Healthcare (NASDAQ:VMD) wird seine Ergebnis-Konferenzschaltung zum dritten Quartal 2025 am Donnerstag, den 6. November 2025, um 11:00 Uhr Eastern Time abhalten. Die Teilnehmer können sich telefonisch unter (877) 407-6176 (US gebührenfrei) oder +1 (201) 689-8451 (international) verbinden oder über den Live-Audio-Webcast unter https://event.choruscall.com/mediaframe/webcast.html?webcastid=asCOlSnC teilnehmen. Eine Wiederholung steht im Bereich Investor Relations der Viemed-Website unter https://www.viemed.com zur Verfügung. Der Call behandelt Viemed's Ergebnisse des Q3 2025 und damit verbundene Hinweise für Investoren und Analysten.
Viemed Healthcare (NASDAQ:VMD) ستعقد اتصال نتائج الربع الثالث من 2025 في الخميس 6 نوفمبر 2025 الساعة 11:00 صباحاً بتوقيت شرق الولايات المتحدة. يمكن للمشاركين الانضمام عبر الهاتف على الرقم (877) 407-6176 (مجاني أمريكي) أو +1 (201) 689-8451 (دولي)، أو عبر البث الصوتي المباشر على الويب https://event.choruscall.com/mediaframe/webcast.html?webcastid=asCOlSnC. ستتوفر إعادة التشغيل في قسم علاقات المستثمرين على موقع Viemed الإلكتروني https://www.viemed.com. تتناول المكالمة نتائج Viemed للربع الثالث من 2025 والتعليقات ذات الصلة للمستثمرين والمحللين.
Viemed Healthcare (NASDAQ:VMD) 将于 2025年11月6日星期四东部时间上午11:00 举行 2025年第三季度收益电话会议。参与者可拨打电话 (877) 407-6176（美国免费）或 +1 (201) 689-8451（国际），或通过现场音频广播在 https://event.choruscall.com/mediaframe/webcast.html?webcastid=asCOlSnC 参与。回放将可在 Viemed 网站的投资者关系部分 https://www.viemed.com 找到。此次电话会议涵盖 Viemed 2025 年第三季度的业绩及对投资者和分析师的相关解读。
- None.
- None.
LAFAYETTE, LA / ACCESS Newswire / October 21, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that it will host its Third Quarter 2025 Earnings Conference Call on Thursday, November 6, 2025, at 11:00 a.m. ET.
Interested parties may participate in the call by dialing:
(877) 407-6176 (US Toll-Free)
+1 (201) 689-8451 (International)
Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=asCOlSnC
Following the live call, a replay will be available in the Investor Relations section of the Company's website at https://www.viemed.com.
ABOUT VIEMED HEALTHCARE, INC.
Viemed is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. Viemed focuses on efficient and effective in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. Visit our website at https://www.viemed.com.
For further information, please contact:
Investor Relations
ir@viemed.com
Trae Fitzgerald
Chief Financial Officer
Viemed Healthcare, Inc.
(337) 504-3802
SOURCE: Viemed Healthcare, Inc.
View the original press release on ACCESS Newswire
FAQ
When is Viemed Healthcare's Q3 2025 earnings call (VMD)?
How can I join the Viemed (VMD) earnings call on November 6, 2025?
Where is the Viemed (VMD) earnings call webcast and replay available?
What topics will Viemed (VMD) cover on the Q3 2025 call?
Is there a toll-free number for U.S. investors for the VMD Q3 2025 call?
